Akinola Soyode-Johnson

This inventor holds 22 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Receptor Modulators. Top assignees: Janssen Pharmaceutica Nv, Janssen Pharmaceutica. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akinola Soyode-Johnson. Retrieved from https://idiyas.com/inventor/akinola-soyode-johnson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 3)

% Patents Active = 95.5

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 9.1

ph-index = 10

Forward Citations = 204(Granted Patents)

Company Filing History:

21 out of 2,101

Janssen Pharmaceutica Nv

patents

1 out of 32

Janssen Pharmaceutica

patents

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

P2X7

GluN2B

Orexin Receptor

1H-Imidazo

Pyrazolo-Pyridine

1,2,3-Triazoles

4-Azaindoles

NMDA Modulators

Substituted Compounds

Pharmacology

Drug Development

Selective Modulation

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338243 - P2X7 modulators (2025-06-24),

2. 12247027 - P2X7 modulators (2025-03-11),

3. 12172997 - Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators (2024-12-24),

4. 11820770 - P2X7 modulators (2023-11-21),

5. 11759455 - Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators (2023-09-19),

6. 11618750 - Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators (2023-04-04),

7. 11225478 - P2X7 modulators (2022-01-18),

8. 11207298 - Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators (2021-12-28),

9. RE48841 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators (2021-12-06),

10. 10766880 - Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators (2020-09-08),

11. 10703749 - P2X7 modulators (2020-07-07),

12. 10617676 - Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulators (2020-04-14),

13. 10377753 - Substituted 4-azaindoles and their use as GluN2B receptor modulators (2019-08-13),

14. 10233173 - Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators (2019-03-19),

15. 10150765 - P2X7 modulators (2018-12-11),

Title: Top Inventor in San Diego

Introduction: Tao Luo is recognized as a leading inventor in San Diego, known for his innovative contributions to various fields.

Latest Patents: His recent patents include advancements in technology and engineering that have garnered attention in the industry.

Career Highlights: Throughout his career, Tao has achieved significant milestones, establishing himself as a prominent figure in the invention community.

Collaborations: He has collaborated with various organizations and institutions, enhancing his impact on technological advancements.

Conclusion: Tao Luo continues to inspire future inventors with his groundbreaking work and dedication to innovation.

Profile summary based on public USPTO records.